When comparing our results with other radiolabeled MG analogs which are currently under clinical investigation, DOTA-MGS5 and DOTA-[(N-Me)1Nal8]MGS5 exhibit a two to five-fold increase in tumor uptake. The gene discussed is MGAM; the disease is neoplasm.